serine/threonine Kinase 17a (STK17A) (N-Term) Peptide
STK17A
Reactivity: Human
BP
Sodium azide
-
- Target See all STK17A products
- STK17A (serine/threonine Kinase 17a (STK17A))
- Protein Region
- N-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
15 amino amino terminus of human DRAK1.
Human
-
-
- Application Notes
- DRAK1 peptide is used for blocking the activity of DRAK1.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- STK17A (serine/threonine Kinase 17a (STK17A))
- Synonyms
- STK17A Peptide, DRAK1 Peptide, RDRAK1 Peptide, serine/threonine kinase 17a Peptide, serine/threonine kinase 17a L homeolog Peptide, STK17A Peptide, stk17a Peptide, stk17a.L Peptide
-
You are here:
